Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SNCA

Seneca Biopharma (SNCA) Stock Price, News & Analysis

Seneca Biopharma logo

About Seneca Biopharma Stock (NASDAQ:SNCA)

Key Stats

Today's Range
$2.30
$2.51
50-Day Range
$1.39
$10.25
52-Week Range
$0.50
$2.67
Volume
36,749 shs
Average Volume
3.78 million shs
Market Capitalization
$41.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Seneca Biopharma, Inc., a clinical stage biopharmaceutical company, develops novel treatments for diseases of high unmet medical needs. The company's stem cell-based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. It is developing NSI-566, which has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease, as well as in Phase II clinical trial for the treatment of chronic ischemic stroke and in Phase I clinical trial for the treatment of chronic spinal cord injury; and NSI-189 that has completed Phase II clinical trials for the treatment of major depressive disorder. The company was formerly known as Neuralstem, Inc. and changed its name to Seneca Biopharma, Inc. in October 2019. Seneca Biopharma, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Receive SNCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seneca Biopharma and its competitors with MarketBeat's FREE daily newsletter.

SNCA Stock News Headlines

Top "Sleeping Giant" Crypto In The Market Now
Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.
Seneca Foods Corp Class A
West Seneca West Senior High School
Seneca High School
See More Headlines

SNCA Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Seneca Biopharma investors own include iBio (IBIO), Matinas BioPharma (MTNB), Ocugen (OCGN), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Bionano Genomics (BNGO) and Artelo Biosciences (ARTL).

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:SNCA
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-8,350,000.00
Net Margins
-230.34%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10,000.00
Book Value
$1.33 per share

Miscellaneous

Free Float
N/A
Market Cap
$41.16 million
Optionable
Not Optionable
Beta
1.83
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:SNCA) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners